TYSABRI for Multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7,629 adverse event reports in the FDA FAERS database where TYSABRI was used for Multiple sclerosis.
Most Reported Side Effects for TYSABRI
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Multiple sclerosis relapse | 811 | 9.9% | 8 | 241 |
| Fatigue | 759 | 9.2% | 0 | 56 |
| Malaise | 523 | 6.4% | 1 | 37 |
| Gait disturbance | 445 | 5.4% | 2 | 32 |
| Multiple sclerosis | 443 | 5.4% | 9 | 57 |
| Memory impairment | 422 | 5.1% | 0 | 26 |
| Headache | 368 | 4.5% | 0 | 34 |
| Drug ineffective | 329 | 4.0% | 2 | 25 |
| Asthenia | 328 | 4.0% | 3 | 49 |
| Fall | 324 | 4.0% | 8 | 99 |
| Nasopharyngitis | 310 | 3.8% | 0 | 14 |
| Urinary tract infection | 308 | 3.8% | 12 | 117 |
| Pain | 274 | 3.3% | 1 | 37 |
| Balance disorder | 260 | 3.2% | 1 | 25 |
| Hypoaesthesia | 259 | 3.2% | 0 | 32 |
Other Indications for TYSABRI
Relapsing-remitting multiple sclerosis (198)
Product used for unknown indication (190)
Crohn's disease (157)
Maternal exposure timing unspecified (15)
Exposure via father (5)
Other Drugs Used for Multiple sclerosis
DIMETHYL (78,567)
NATALIZUMAB (56,733)
INTERFERON BETA-1A (56,475)
FINGOLIMOD (43,123)
TERIFLUNOMIDE (29,963)
DALFAMPRIDINE (28,787)
GLATIRAMER (27,144)
OCRELIZUMAB (15,501)
OFATUMUMAB (11,816)
PEGINTERFERON BETA-1A (11,105)